Stay updated on Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the study record for the temozolomide and nivolumab colorectal cancer trial, including its design, eligibility criteria, and record details, instead of a 403 error.
    Difference
    46%
    Check dated 2026-11-09T12:33:28.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site as revision v3.8.0 instead of v3.7.2. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T11:54:12.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A banner announces that NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” in response to an executive order, with links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T11:13:18.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2; the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T12:11:18.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T13:58:15.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the usual study details, indicating the record is temporarily inaccessible or restricted.
    Difference
    18%
    Check dated 2026-09-21T20:41:46.000Z thumbnail image

Stay in the know with updates to Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page.